The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression

Leukemia and Lymphoma

Volumn 23, Issue 5-6, 1996, Pages 551-560

  Zauli, Giorgio ^a   Gibellini, Davide ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Bcl 2; HIV 1; Tat

Indexed keywords

CYTOKINE; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

APOPTOSIS; DNA TRANSFECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; MONONUCLEAR CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW;

EID: 0030468011     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054864     Document Type: Review

References (93)

1. Jones, K. A. and Peterlin, M. B. (1994) Control of RNA initiation and elongation at the HIV-1 promoter Annu. Rev. Biochem., 63, 717-743.
2. Ranki, A , Lagerstedt, A., Ovod, V , Aavik, E. and Krohn, K. J. E. (1994) Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol., 139, 365-378.
3. Laspia, M. F., Rice, A. P. and Mathew, M. B. (1989) HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell, 59, 283-292.
4. Marciniak, R. A., Calnan, B. J., Frankel, A. D and Sharp, P. A. (1990) HIV-1 Tat protein trans-activates transcription in vitro. Cell, 63, 791-802.
5. Cullen, B. R (1993) Does HIV-1 tat induce a change in viral initiation rights? Cell, 73, 417-419.
6. Koken, S. E. C., Greijer, A. E., Verhoef, K., van Wamel, J., Bukrinskaya, A G. and Berkout, B. (1994) Intracellular analysis of in vitro modified HIV Tat protein. J. Biol. Chem , 269, 8366-8374
7. Dang, C V. and Lee, W. M. F. (1989) Nuclear and nucleolar targeting sequences of c-erb-A, c-myc, N-myc, p53, HPS70, and HIV tat proteins. J. Biol. Chem., 264, 18019-18023.
8. Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D , Singh, M., Skinner, M. A. and Valerio, R (1989) HIV-1 tat protein binds transactivation-response region (TAR) in vitro. Proc. Natl. Acad. Sci. USA, 86, 6925-6932.
9. Taylor, J. P., Kunda, M. and Khalili, K. (1993) TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. Virol., 195, 780-788.
10. Huang, L., Joshi, A., Willey, R., Orenstein, J. and Jeang, K. T. (1994) Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J., 13, 2886-2893.
11. Ensoli, B., Barillari, G., Zaki Salahuddin, S., Gallo, R C. and Wong-Stall, F. (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lessons of AIDS patients. Nature, 345, 84-86.
12. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R. A., Wingfield, P. and Gallo, R. C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 tat protein on cell growth and viral transactivation. J. Virol., 67, 277-287.
13. Milani, D., Zauli, G., Neri, L. M., Marchisio, M., Previati, M. and Capitani, S. (1993) Influence of the human immunodeficiency virus type 1 tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J. Gen. Virol, 74, 2587-2594.
14. Frankel, A. D. and Pabo, C. O. (1988) Cellular uptake of the Tat protein from Human immunodeficiency virus. Cell, 55, 1189-1193.
15. Mann, D. A. and Frankel, A. D. (1991) Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J., 10, 1733-1739.
16. Bonifaci, N., Sitia, R. and Rubartelli, A. (1995) Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS, 9, 995-1000.
17. Fawell, S , Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B. and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl Acad. Sci. USA, 91, 664-671.
18. Nigg, E. A., Baeuerle, P A. and Luhrmann, R. (1991) Nuclear-import-export: in search of signals and mechanisms. Cell, 66, 15-22.
19. Marasco, W. A., Szilvay, A. M., Kailand, K. H., Heiland, D. G., Reyes, H. M. and Walter, R. J. (1994) Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells. Arch.Virol., 139, 133-154.
20. Paine, P. L., Moore, L. C. and Horowitz, S. B. (1990) Nuclear protein import in permeabilized mammalian cells requires soluble cytoplasmic factors. J. Cell Biol., 11, 807-816.
21. Olsnes, S., Moskaug, J. O., Stenmark, H. and Sandvig, K. (1988) Diphtheria toxin entry: protein translocation in the reverse direction. Trends Biochem. Sci., 13, 348-351.
22. Abraham, J A., Mergia, A., Whang, J. L., Tumolo, A., Friedman, J., Hjerrild, K. A., Gospodarowicz, D. and Fiddes, J. C. (1986) Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science, 233, 545-548.
23. Rusnati, M., Coltrini, D., Caccia, P., Dell'Era, P., Zoppetti, G., Oreste, P., Valsasina, B. and Presta, M. (1994) Distinct role of 2-O-, N-, and 6-0-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. Biochem. Biophis. Res. Commu., 203, 250-258.
24. Brake, D. A., Debouck, C. and Biesecher, G. (1990) Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type I transactivation protein, tat. J. Cell Biol., 111, 1275-1281.
25. Barillari, G., Gendelman, R., Gallo, R. C. and Ensoli, B. (1993) The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same types by using integrin receptors recognizing RGD amino acid sequence. Proc. Natl. Acad. Sci. USA. 90, 7941-7945.
26. Vogel, B. E., Lee, S. J., Hildebrand, A., Craig, W., Pierschbacher, M. D., Wong-Staal, F. and Ruoslahti, E. (1993) A novel integrin specitlcify exemplified by binding of the α, β5 integrin to the basic domain of the HIV tat protein and vitronectin. J. Cell Biol., 121, 461-168.
27. Weeks, B. S , Desai, K., Loewenstein, P. M , Klotman, M. E., Klotman, P., Green, M. and Kleinman, H. K. (1993) Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J. Biol. Chem., 268, 5279-5284.
28. Albini, A., Fontanini, G., Masiello, L., Tacchetti, C., Bigini, D., Luzzi, P., Noonan, D. M. and Stetler-Stevenson, W. G. (1994) Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS, 8, 1237-1244.
29. Ensoli, B., Gendelman, R., Markham, P., Fiorelli, V., Colombini, S., Raffeld, M., Cafaro, A., Chang, H. K., Brady, J. N. and Gallo, R. C. (1994) Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature, 371, 674-680
30. Kim, C. M., Vogel, J., Jay, G. and Rhim, J. S. (1992) The HIV tat gene transforms human keratinocytes. Oncogene, 7, 1525-1529.
31. Zauli, G., Gibellini, D., Milani, D., Mazzoni, M , Borgatti, P., La Placa, M. and Capitani, S. (1993) Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res., 53, 4481-4485.
32. Caputo, A., Sodroski, J. G. and Haseltine, W. A. (1990) Constitutive expression of HIV-1 tat protein in human Jurkat T cells using a BK virus vector. J. AIDS, 3, 372-379.
33. Zauli, G., Marchisio, M., Bertagnolo, V., Celeghini, C. and Capitani, S. (1994) HIV-1 Tat protein suppresses the nerve growth factor (NGF)-mediated differentiation of PC12 rat phechromocytoma cell line. Oncology Reports, 1, 773-777.
34. Fauci, A. S. (1993) Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science, 262, 1011-1018.
35. Gibellini, D., Caputo, A., Celeghini, C., Bassini, A., La Placa, M., Capitani, S. and Zauli, G. (1995) Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br. J. Haematol., 89, 24-33.
36. Zauli, G., Gibellini, D., Caputo, A., Bassini, A., Negrini, M., Monne, M., Mazzoni, M. and Capitani, S. (1995) The human immunodeficiency virus type-1 (HIV-1) Tat protein upregulates Bcl-2 gene expression in Jurkat T cell lines and primary peripheral blood mononuclear cells. Blood, 86, 3823-3834.
37. Vogel, J., Hinrichs, S. H., Reynolds, R. K., Luciw, P. A. and Jay, G. (1988) The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice Nature, 335, 606-611.
38. Vogel, J., Hinrichs, S. H., Napolitano, L. A., Ngo, L. and Jay, G. (1991) Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res., 51, 6686-6690.
39. Vellutini, C., Horschowski, N., Philippen, V., Gambarelli, D., Nave, K. A. and Filippi, P. (1995) Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene. AIDS Res. Hu. Retro., 11, 21-29.
40. Corallini, A., Altavilla, G., Pozzi, L., Bignozzi, F., Negrini, M., Rimessi, P , Gualandi, F. and Barbanti-Brodano, G. (1993) Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different hystotypes. Cancer Res., 53, 5569-5576.
41. Harnly, M. E., Swan, S. H., Holly, E. A., Kelter, A. and Padian, N. (1988) Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies m a population with a high incidence of acquired immunodeficiency syndrome (AIDS). Am. J. Epidemiol. 128, 261-274.
42. Viscidi, R. P., Mayur, K., Lederman, H. M and Frankel, A. D. (1989) Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science, 246, 1606-1608.
43. Subramanyam, M., Gutheil, W. G., Bachovchin, W. W. and Huber, B. T. (1993) Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol., 150, 2544-2553.
44. Chirmule, N., Than, S., Khan, S. and Pahwa, S. (1995) Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J. Virol., 69, 492-498.
45. Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K , Dhein, J., Walczak, H., Debatin, K. M. and Krammer, P. H. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature, 375, 497-500.
46. Li, C. J., Friedman, D. J., Wang, C., Metelev, V. and Pardee, A. B. (1995) Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science, 268, 229-231
47. Purvis, S. F., Jacobberger, J W., Sramkoski, R. M , Patki, A. H. and Lederman, M. M. (1995) HIV type 1 Tat protein induces apopotosis and death in Jurkat cells. AIDS Res. Hu. Retro., 11, 443-451.
48. Philippon, V., Vellutini, C., Gambarelli, D., Harkiss, G., Arbuthnott, G., Metzger, D., Roubin, R. and Filippi, P. (1994) The basic domain of the lentivirai Tal protein is responsible for damages in mouse brain: involvment of cytokines Virology, 205, 519-529.
49. Magnuson, D. S., Knudsen, B. E., Geiger, J. D., Brownstone, R. M. and Nath, A. (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol., 37, 373-380.
50. Zauli, G., La Placa, M , Vignoli, M , Re, M. C., Gibellini, D., Furlini, G., Milani, D., Marchisio, M., Mazzoni, M. and Capitani, S. (1995) An automne loop of HIV type 1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J. AIDS, 10, 306-316.
51. Meyaard, L., Otto, S. A., Schuitemaker, H. and Miedema, F. (1992) Effects of HIV-1 Tat protein on human T cell proliferation. Eur. J. Immunol., 22, 2729-2736.
52. Buonaguro, L., Buonaguro, F. M., Giraldo, G. and Ensoli, B. (1994) The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J. Virol., 68, 2677-2682.
53. Sastry, K. J., Reddy, H. R., Pandita, R., Tolpal, K. and Aggarwal, B. B. (1990) HIV-1 tat induces tumor necrosis factor-beta (lymphotoxin) in a human B lymphoblastoid cell line. J. Biol. Chem., 265, 20091-20093.
54. Buonaguro, L., Barillari, G., Chang, H. K., Bohan, C. A., Kao, V., Morgan, R., Gallo, R. C. and Ensoli. B. (1992) Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokine. J Virol., 66, 7159-7167.
55. Sharma, V., Knobloch, T. J. and Benjamin, D. (1995) Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines. Biochem Biophys. Res. Commu., 208, 704-713.
56. Biswas, D. K., Salas, T. R., Wang, F., Ahlers, C. M , Dezube, B. J. and Pardee, A. B. (1995) A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol., 69, 7437-7444.
57. Scala, G., Ruocco, M. R., Ambrosino, C., Mallardo, M., Giordano, V., Baldassarre, F., Dragonetti, E., Quinto, I. and Venuta, S. (1994) The expression of the interieukin 6 gene is induced by the human immunodeficiency virus 1 tat protein J. Exp. Med., 179, 961-971.
58. Puri, R. K. and Aggarual, B. B. (1992) Human immunodeficiency virus type 1 tat gene up-regulates interleukin-4 receptors on a human B-lymphoblastoid cell line. Cancer Res., 52, 3787-3790.
59. Gibellini, D , Zauli, G., Re, M. C , Milani, D., Furlini, G., Caramelli, E., Capitani, S. and La Placa, M. (1994) Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially upregulates IL-6 and TGF-β1 mRNA expression and protein synthesis in peripheral blood monocytes Br J. Haematol., 88, 261-267.
60. Zauli, G., Davis, B R., Re, M. C., Visani, G., Furlini, G. and La Placa, M. (1992) Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for HIV-1 induced hematopoietic suppression. Blood, 80, 3036-3043.
61. Cupp, C. Taylor, P., Khalili, K. and Amini, S. (1993) Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene, 8, 2231-2236.
62. Lotz, M., Clark-Lewis, I and Ganu, V (1994) HIV-1 transactivator protein Tat induces proliferation and TGFβ expression in human articular chondrocytes. J. Biol. Chem., 124, 365-371
63. Westendorp, M. O., Li-Weber, M., Frank, R. W and Krammer, P. H. (1994) Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68, 4177-4185.
64. Purvis, S. F., Georges, D. L., Williams, T. M. and Lederman, M. M. (1992) Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. Cell. Immunol. 144, 32-42
65. Puri, R. K., Leland, P. and Aggarwal, B. B. (1995) Constitutive expression of human immunodeficiency virus type 1 tat gene inhibits interieukin 2 and interieukin 2 receptor expression in a human CD4+ T lymphoblastoid (H9) cell line. AIDS Res. Hu. Retro., 11, 31-40.
66. Korsmeyer, S. J. (1992) Bcl-2: a repressor of lymphocyte death. Immunol. Today, 13, 285-290.
67. Oltvai, Z. N., Milliman, C. L. and Korsmeyer, S J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homology, Bax, that accelerates programmed cell death. Cell, 74, 609-618.
68. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J. A and Reed, J. C. (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80, 279-288.
69. L and Bcl-2, displaces Bax and promotes cell death. Cell. 80, 285-293.
70. Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J. and Nunez, O. (1994) Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J., 13, 683-692.
71. Caputo, A., Grossi, M. P., Bozzini, R., Rossi, C., Betti, M., Marconi, P. C., Barbanti-Brodano, G. and Balboni, P. G. (1996) Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region. Gene Therapy, 3, 235-245.
72. Longo, F., Marchetti, M. A., Castagnoli, L., Battaglia, P. A. and Gigliani, F. (1995) A novel approach to protein-protein interaction: complex formation between p53 tumor suppressor and the HIV Tat proteins. Biochem. Biophys. Res. Commu , 206, 326-334.
73. Li, C. J., Wang, C., Friedman, D. J. and Pardee, A. B. (1995) Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA., 92, 5461-5464.
74. Flores, S C., Marecki, J. C., Harper, K. P., Bose, S. K., Nelson, S. K. and Mc Cord, J. M. (1993) Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in Hela cells. Proc. Natl Acad. Sci. USA. 90, 7632-7636.
75. Ursini, M. V., Lettien, T., Braddock, M. and Martini, G. (1993) Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat. Virol., 196, 338-343.
76. Church, S. L., Grant, J. M., Ridnour, L. A., Oberley, L. W., Swanson, P. E., Meltzer, P. S. and Trent, J. M. (1993) Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. U.S A., 90, 3113-3117.
77. Nabel, G. and Baltimore, D. (1987) An inducible transcription factor activates expression of human immmunodeficiency virus in T-cell. Nature, 326, 711-713.
78. Roulston, A., Lin, R., Beauparlant, P., Wainberg, M. A. and Hiscott, J. (1995) Regulation of human immunodeficiency virus type-1 and cytokine gene expression in myeloid cells by NF-kB/Rel transcription factors. Microbiol. Rev., 59, 481-505.
79. Alcamì, J., Lain de Lera, T., Folgueira, L., Pedraza, M. A., Jacque, J. M., Bachelerie, F., Noriega, A. R., Hay, R. T., Harrich, D., Gaynor, R. B., Virelizier, J. L. and Arenzana-Seisdedos, F. (1995) Absolute dependence of kB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO (Eur. Mol Biol. Organ.) J., 14, 1552-1560.
80. Demarchi, F., D'Agaro, P., Falaschi, A. and Giacca, M. (1993) In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency viras type 1. J. Virol. 67, 7450-7460.
81. Westendorp, M. O., Shatrov, V A., Schulze-Osthoff, K., Frank, R., Kraft, M., Los, M., Krammer, P. H., Droge, W. and Lehmann, V. (1995) HIV-1 Tat potentiates TNF-induced NF-kB activation and cytotoxicity by altering the cellular redox state. EMBO (Eur. Mol. Biol. Organ.) J., 14, 546-556.
82. Campioni, D., Corallini, A., Zauli, G., Possati, L., Altavilla, G. and Barbanti-Brodano, G (1995) HIV-1 type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis. AIDS Res. Hu. Retro., 1039-1048.
83. Steinaa, L., Serensen, A. M., Nielsen, J O. and Hansen, J. E. S. (1994) Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch. Virol. 139, 263-271.
84. Re, M. C., Furlini, G., Vignoli, M., Ramazzotti, E., Roderigo, G., De Rosa, V., Zauli, G., Lolli, S., Capitani, S. and La Placa, M. (1995) Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J. AIDS, 10, 408-416.
85. Krone, W. J., Debouck, C., Epstein, L G , Heutink, P., Meloen, R. and Goudsmit, J. (1988) Natural antibodies to HIV-tat epitopes and expression of HTV-1 genes in vivo. J. Med. Virol. 26, 261-274.
86. Rodman, T. C., Pruslin, F. H., To, S. E. and Winston, R. (1992) Human immunodeficiency virus (HIV) tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope. J. Exp. Med., 175, 1247.
87. Zhang, Z., Vuori, K., Reed, J. C. and Ruoslahti, E. (1995) The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl Acad. Sci. USA., 92, 6161-6170.
88. Yamada, A., Nikaido, T., Nojima, Y., Schlossman, S. F. and Marimoto, C. (1991) Activation of Human CD4 T lymphocytes. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J. Immunol., 146, 53-62.
89. Juliano, R. L. and Varner, J. A. (1993) Adhesion molecules in cancer: the role of integrins Curr. Op. Biol., 5, 812-819.
90. Sandstrom, P. A., Pardi, D., Goldsmith, C. S., Diamond, M. and Folks, T. M. (1996) Bcl-2 expression facilitates HIV-1-mediated cytopathic effects during acute spreading infections. 3rd Conference on Retroviruses and Opportunistic Infections, Abs., 92, January 28-February 1, 1996, Washington, DC.
91. Herndier, B. G., Kaplan, L. D. and McGrath, M. S. (1994) Pathogenesis of AIDS lymphomas. AIDS, 8, 1025-1044.
92. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M. and Korsmeyer, S. J. (1991) Bcl-2 protein is topographically restricted in tissues characterized by apopototic cell death. Proc. Natl. Acad. Sci. USA, 88, 6961-6965.
93. Akbar, A N., Borthwick, N., Salmon, M., Gombert, W., Bofill, M., Shamsadeen, N., Pilling, D , Pen, S , Grundy, J. E. and Janossy, G. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J. Exp. Med., 178, 427-438.